Bulletin 20-04
Division of Insurance
Carriers should waive any cost-sharing for lab testing for respiratory syncytial virus (RSV), influenza, respiratory panel tests, and COVID-19 for enrollees meeting CDC criteria; utilization of telehealth; assess preparedness plans.